Recipient-based approach to tailoring immunosuppression in liver transplantation

Area of Science:

• Transplantation Medicine
• Immunology
• Hepatology

Background:

• Significant advances in liver transplant immunosuppression (IS) have improved long-term survival rates.
• However, survival outcomes remain variable, influenced by recipient, donor, and perioperative factors.
• There is a growing interest in tailoring IS based on individual recipient characteristics.

Purpose of the Study:

• To review the current literature on the impact of recipient-specific factors on immunosuppression therapy in liver transplant recipients.
• To explore the effects of various IS drugs concerning recipient age, ethnicity, and liver disease etiology.
• To highlight the need for a consensus on individualized IS strategies for liver transplant patients.

Main Methods:

• Comprehensive literature search of studies investigating immunosuppression in liver transplantation.
• Analysis of data focusing on the influence of recipient factors (age, ethnicity, liver disease etiology) on IS drug efficacy and outcomes.
• Synthesis of findings to identify trends and gaps in current knowledge.

Main Results:

• IS drug efficacy and side effect profiles can be influenced by patient age, with potential differences in metabolism and response.
• Ethnic variations may exist in the response to certain IS medications, necessitating careful monitoring.
• The underlying etiology of liver disease can impact the choice and effectiveness of IS regimens.

Conclusions:

• Individualized immunosuppression therapy holds promise for optimizing liver transplant outcomes.
• Further research is needed to establish evidence-based guidelines for tailoring IS based on recipient factors.
• Developing consensus recommendations for personalized IS is crucial for advancing liver transplant care.